| Bioactivity | SARS-CoV-2 3CLpro-IN-1 (Compound 14c) is a potent inhibitor of SARS-CoV-2 3CLpro. 3CLpro (main coronaviruses cysteine-protease) has been identified as a promising target for the development of antiviral drugs. SARS-CoV-2 3CLpro-IN-1 has the potential for the research of infection diseases[1]. |
| Name | SARS-CoV-2 3CLpro-IN-1 |
| CAS | 2757970-20-8 |
| Formula | C27H30ClN3O3S |
| Molar Mass | 512.06 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Stille JK, et al. Design, synthesis and in vitro evaluation of novel SARS-CoV-2 3CLpro covalent inhibitors. Eur J Med Chem. 2022 Feb 5;229:114046. |
SARS-CoV-2 3CLpro-IN-1
CAS: 2757970-20-8 F: C27H30ClN3O3S W: 512.06
SARS-CoV-2 3CLpro-IN-1 (Compound 14c) is a potent inhibitor of SARS-CoV-2 3CLpro. 3CLpro (main coronaviruses cysteine-pr
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.